Evidence map›Paper›PMID 32393645›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Evolution of vancomycin-resistant

Gayatri Shankar Chilambi, Hayley R Nordstrom, Daniel R Evans, Jose A Ferrolino, Randall T Hayden, Gabriela M Marón, Anh N Vo, Michael S Gilmore, Joshua Wolf, Jason W Rosch and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Linezolid in the Focus of Antimicrobial Resistance ofInternational journal of molecular sciences · 2025
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. bioRxiv : the preprint server for biology · 2025
    Article
  20. Clinical, genomic, and functional characterization of vancomycin-resistantFrontiers in cellular and infection microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Gayatri Shankar ChilambiDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213.ORCID 0000-0001-5247-5399
Hayley R NordstromDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213.
Daniel R EvansDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213.
Jose A FerrolinoDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105.ORCID 0000-0003-4008-5507
Randall T HaydenDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105.
Gabriela M MarónDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105.
Anh N VoDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105.
Michael S GilmoreDepartment of Ophthalmology, Harvard Medical School and Massachusetts Eye and Ear Infirmary, Boston, MA 02114.
Joshua WolfDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105.
Jason W RoschDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105.ORCID 0000-0002-1798-1760
Daria Van TyneDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213; vantyne@pitt.edu.ORCID 0000-0001-7284-0103
St. Jude Children's Research Hospital · USUniversity of Pittsburgh · USMassachusetts Eye and Ear Infirmary · US

Funding

Technical Mother Machine CoreP01AI083214 · NIAID · SCHEPENS EYE RESEARCH INSTITUTE · PI Michael S Gilmore · 2009 to 2026
$39.4M
Predicting the emergence of antibiotic resistance through multi-omics approaches and Immune System-surveillanU01AI124302 · NIAID · BOSTON COLLEGE · PI BENTO, JOSE, COOPER, VAUGHN · 2016 to 2020
$10.2M
Pneumococcal pathogenesis in sickle cell diseaseR01AI110618 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI ROSCH, JASON W. · 2015 to 2019
$2.2M
Bacterial Evasion of Innate Defenses at the Ocular SurfaceR00EY028222 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VAN TYNE, DARIA N · 2018 to 2020
$728k
Bacterial Evasion of Innate Defenses at the Ocular SurfaceK99EY028222 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI VAN TYNE, DARIA N · 2017 to 2017
$95k
NEI NIH HHS K99 EY028222NEI NIH HHS R00 EY028222NIAID NIH HHS P01 AI083214NIAID NIH HHS R01 AI110618NIAID NIH HHS U01 AI124302
6 · The paper itself

Abstract

Patients with hematological malignancies or undergoing hematopoietic stem cell transplantation are vulnerable to colonization and infection with multidrug-resistant organisms, including vancomycin-resistant

Indexed as

Enterococcus faeciumVancomycin-Resistant EnterococciAnti-Bacterial AgentsBacteremiaBiofilmsChildEvolution, MolecularFemaleGastrointestinal MicrobiomeGenome, BacterialGram-Positive Bacterial InfectionsHumansImmunocompromised HostMaleMutationSorbitolAnti-Bacterial AgentsSorbitolfunctional genomicspediatric infectious diseasesvancomycin-resistant enterococci

Identifiers

PMID32393645
PMCPMC7261057
OpenAlexW3022172161

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.